Giuseppe Remuzzi, MD - Clinical Trial Investigator | Syfrah

Trials Sponsors Conditions Drugs Pricing

Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(4)

MIXED(3)

DEVICE(2)

DIAGNOSTIC_TEST(2)

In-house ELISA, and ELISA kits from "DBA Italy" (Abbexa).

mario-negri-institute-for-pharmacological-research

mario-negri-institute-for-pharmacological-research

mario-negri-institute-for-pharmacological-research

Dapagliflozin 10Mg Tab

mario-negri-institute-for-pharmacological-research

Veltassa Oral Powder Product

mario-negri-institute-for-pharmacological-research

mario-negri-institute-for-pharmacological-research

PerLife PerKidney

mario-negri-institute-for-pharmacological-research

mario-negri-institute-for-pharmacological-research

+4 more interventions

12 unique interventions5 categories

Analytics

Trial Phases

Phase 22

Phase 31

Trial Status

Completed3

Recruiting3

Terminated1

Other4

Role Distribution

Other Roles11

Activity Timeline

Clinical Trials (11)

NCT06797609Active Not Recruiting

Comparing the Performance of Serum Creatinine and Cystatin C-based GFR Estimations in Predicting Directly Measured GFR in Patients With or Without Nephrotic Syndrome

Nephrotic Syndrome

StudydirectorStart date: 2025-04-01

NCT06242327Recruiting

An Outcome Analysis of Primary Membranous Nephropathy

Membranous Nephropathy

StudydirectorStart date: 2024-11-29

NCT06374121Not ApplicableRecruiting

Kidney Perfusion With or Without Absorption

Kidney Replacement

StudychairStart date: 2024-10-22

NCT06374095Active Not Recruiting

1 vs 7 RATG Infusions in Renal Transplantation

Kidney Replacement

StudychairStart date: 2024-07-30

NCT06334692Recruiting

Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome

Nephrotic Syndrome

StudydirectorStart date: 2024-03-19

NCT06193616Active Not Recruiting

Outcome of ADPKD With Octreotide LAR

Autosomal Dominant Polycystic Kidney

StudydirectorStart date: 2024-02-12

NCT05786469Phase 3Terminated

Patiromer Trial in CKD Stage IIIB to V

Hyperkalemia

StudydirectorStart date: 2023-08-02

NCT05229263Not ApplicableActive Not Recruiting

Multiparametric MRI in Healthy Volunteers and CKD Patients

Chronic Kidney DiseasesHealthy

StudychairStart date: 2022-11-25

NCT04794517Phase 2Completed

Dapagliflozin in Non-diabetic Stage IV CKD

Chronic Kidney Diseases

StudydirectorStart date: 2021-11-08

NCT04893096Phase 2Completed

MOR202 for Refractory MN

Membranous Nephropathy

StudydirectorStart date: 2021-10-22

Showing 10 of 11 trials

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

CO

High-influence Collaborator

CO

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Nephrotic Syndrome3 Chronic Kidney Diseases2 Kidney Replacement2 Glomerulonephritis, Membranous2 Polycystic Kidney, Autosomal Dominant1 Healthy1 Hyperkalemia1

Affiliations

Istituto Di Ricerche Farmacologiche Mario Negri

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Shared therapeutic areas:

HealthyChronic Kidney Diseases

Similarity Score9%

Melda Saglam, PhD

Hacettepe University

Shared therapeutic areas:

Chronic Kidney DiseasesHealthy

Similarity Score9%

Hamid Gourabi, PhD

head of Royan Institute

Shared therapeutic areas:

Chronic Kidney Diseases

Similarity Score4%

emilie garrido pradalie

APHM

Shared therapeutic areas:

Similarity Score4%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Shared therapeutic areas:

Chronic Kidney Diseases

Similarity Score4%

Waqar ahmed awan, Phd

Riphah International University

Shared therapeutic areas:

Similarity Score4%

Hagop Youssoufian, MD

Verastem, Inc.

Shared therapeutic areas:

Similarity Score4%

Murad Alam, MD

Northwestern University

Shared therapeutic areas:

Similarity Score4%

Ahmed Elshafeey, Ph.D. Pharma

Genuine Research Center

Shared therapeutic areas:

Similarity Score4%

Suman Sheraz, PhD*

Riphah International University

Shared therapeutic areas:

Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (11)

Showing 11 of 11 trials

NCT06797609StudyDirector

Comparing the Performance of Serum Creatinine and Cystatin C-based GFR Estimations in Predicting Directly Measured GFR in Patients With or Without Nephrotic Syndrome

Nephrotic Syndrome

Active Not Recruiting

NCT06242327StudyDirector

An Outcome Analysis of Primary Membranous Nephropathy

Membranous Nephropathy

Recruiting

NCT06374121Not ApplicableStudyChair

Kidney Perfusion With or Without Absorption

Kidney Replacement

Recruiting

NCT06374095StudyChair

1 vs 7 RATG Infusions in Renal Transplantation

Kidney Replacement

Active Not Recruiting

NCT06334692StudyDirector

Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome

Nephrotic Syndrome

Recruiting

NCT06193616StudyDirector

Outcome of ADPKD With Octreotide LAR

Autosomal Dominant Polycystic Kidney

Active Not Recruiting

NCT05786469Phase 3StudyDirector

Patiromer Trial in CKD Stage IIIB to V

Hyperkalemia

Terminated

NCT05229263Not ApplicableStudyChair

Multiparametric MRI in Healthy Volunteers and CKD Patients

Chronic Kidney DiseasesHealthy

Active Not Recruiting

NCT04794517Phase 2StudyDirector

Dapagliflozin in Non-diabetic Stage IV CKD

Chronic Kidney Diseases

Completed

NCT04893096Phase 2StudyDirector

MOR202 for Refractory MN

Membranous Nephropathy

Completed

NCT05712369Not ApplicableStudyDirector

B Cells in Idiopathic Nephrotic Syndrome

Nephrotic Syndrome

Completed

All 11 trials loaded